211 related articles for article (PubMed ID: 11320529)
21. Gadolinium periconceptional exposure: pregnancy and neonatal outcome.
De Santis M; Straface G; Cavaliere AF; Carducci B; Caruso A
Acta Obstet Gynecol Scand; 2007; 86(1):99-101. PubMed ID: 17230297
[TBL] [Abstract][Full Text] [Related]
22. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
[TBL] [Abstract][Full Text] [Related]
23. Community-based, prospective, controlled study of obstetric and neonatal outcome of 179 pregnancies in women with epilepsy.
Viinikainen K; Heinonen S; Eriksson K; Kälviäinen R
Epilepsia; 2006 Jan; 47(1):186-92. PubMed ID: 16417548
[TBL] [Abstract][Full Text] [Related]
24. Adverse effects of prenatal methimazole exposure.
Di Gianantonio E; Schaefer C; Mastroiacovo PP; Cournot MP; Benedicenti F; Reuvers M; Occupati B; Robert E; Bellemin B; Addis A; Arnon J; Clementi M
Teratology; 2001 Nov; 64(5):262-6. PubMed ID: 11745832
[TBL] [Abstract][Full Text] [Related]
25. Teratogenic potential of vaginal metronidazole treatment during pregnancy.
Kazy Z; Puhó E; Czeizel AE
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):174-8. PubMed ID: 16316810
[TBL] [Abstract][Full Text] [Related]
26. The safety of cetirizine during pregnancy. A prospective observational cohort study.
Weber-Schoendorfer C; Schaefer C
Reprod Toxicol; 2008 Sep; 26(1):19-23. PubMed ID: 18571373
[TBL] [Abstract][Full Text] [Related]
27. Metamizol (dipyrone, optalgin) in pregnancy, is it safe? A prospective comparative study.
Bar-Oz B; Clementi M; Di Giantonio E; Greenberg R; Beer M; Merlob P; Arnon J; Ornoy A; Zimmerman DM; Berkovitch M
Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):176-9. PubMed ID: 15808375
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study.
Chun-Fai-Chan B; Koren G; Fayez I; Kalra S; Voyer-Lavigne S; Boshier A; Shakir S; Einarson A
Am J Obstet Gynecol; 2005 Mar; 192(3):932-6. PubMed ID: 15746694
[TBL] [Abstract][Full Text] [Related]
29. Maternal fever and birth outcome: a prospective study.
Chambers CD; Johnson KA; Dick LM; Felix RJ; Jones KL
Teratology; 1998 Dec; 58(6):251-7. PubMed ID: 9894674
[TBL] [Abstract][Full Text] [Related]
30. High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study.
Mastroiacovo P; Mazzone T; Addis A; Elephant E; Carlier P; Vial T; Garbis H; Robert E; Bonati M; Ornoy A; Finardi A; Schaffer C; Caramelli L; Rodríguez-Pinilla E; Clementi M
Teratology; 1999 Jan; 59(1):7-11. PubMed ID: 9988877
[TBL] [Abstract][Full Text] [Related]
31. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus infection in pregnancy--a prospective controlled study.
Avgil M; Diav-Citrin O; Shechtman S; Arnon J; Wajnberg R; Ornoy A
Reprod Toxicol; 2008 Aug; 25(4):468-71. PubMed ID: 18534816
[TBL] [Abstract][Full Text] [Related]
33. Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy.
Donders GG; Van Calsteren K; Bellen G; Reybrouck R; Van den Bosch T; Riphagen I; Van Lierde S
BJOG; 2009 Sep; 116(10):1315-24. PubMed ID: 19538417
[TBL] [Abstract][Full Text] [Related]
34. Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations.
Drinkard CR; Shatin D; Clouse J
Pharmacoepidemiol Drug Saf; 2000 Dec; 9(7):549-56. PubMed ID: 11338912
[TBL] [Abstract][Full Text] [Related]
35. Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.
Maschi S; Clavenna A; Campi R; Schiavetti B; Bernat M; Bonati M
BJOG; 2008 Jan; 115(2):283-9. PubMed ID: 17903222
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.
Garbis H; Elefant E; Diav-Citrin O; Mastroiacovo P; Schaefer C; Vial T; Clementi M; Valti E; McElhatton P; Smorlesi C; Rodriguez EP; Robert-Gnansia E; Merlob P; Peiker G; Pexieder T; Schueler L; Ritvanen A; Mathieu-Nolf M
Reprod Toxicol; 2005; 19(4):453-8. PubMed ID: 15749258
[TBL] [Abstract][Full Text] [Related]
37. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis.
Kozer E; Costei AM; Boskovic R; Nulman I; Nikfar S; Koren G
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):70-84. PubMed ID: 12852485
[TBL] [Abstract][Full Text] [Related]
38. First-trimester fetal reduction to a singleton infant or twins: outcome in relation to the final number and karyotyping before reduction by transabdominal chorionic villus sampling.
Brambati B; Tului L; Camurri L; Guercilena S
Am J Obstet Gynecol; 2004 Dec; 191(6):2035-40. PubMed ID: 15592288
[TBL] [Abstract][Full Text] [Related]
39. Prenatal use of metronidazole and birth defects: no association.
Piper JM; Mitchel EF; Ray WA
Obstet Gynecol; 1993 Sep; 82(3):348-52. PubMed ID: 8355932
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
